Economic evaluation of human papillomavirus vaccination in developed countries.
作者： Marc Brisson , Nicolas van de Velde , Marie-Claude Boily
DOI: 10.1159/000214924
关键词:
摘要: Background: With promising efficacy results from randomized control trials of human papillomavirus (HPV) vaccines and the availability new screening paradigms, policymakers are b
cabdirect.org
karger.com 
sci-hub.se 参考文章(38)
Gillian D. Sanders, Al V. Taira, Cost Effectiveness of a Potential Vaccine for Human papillomavirus Emerging Infectious Diseases. ,vol. 9, pp. 37- 48 ,(2003) , 10.3201/EID0901.020168
Harrell W. Chesson, Donatus U. Ekwueme, Mona Saraiya, Lauri E. Markowitz, Cost-effectiveness of human papillomavirus vaccination in the United States. Emerging Infectious Diseases. ,vol. 14, pp. 244- 251 ,(2008) , 10.3201/EID1402.070499
K M French, R V Barnabas, M Lehtinen, O Kontula, E Pukkala, J Dillner, G P Garnett, Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland British Journal of Cancer. ,vol. 96, pp. 514- 518 ,(2007) , 10.1038/SJ.BJC.6603575
Hein J. Boot, Iris Wallenburg, Hester E. de Melker, Marie-José M. Mangen, Annette A.M. Gerritsen, Nicoline A. van der Maas, Johannes Berkhof, Chris J.L.M. Meijer, Tjeerd G. Kimman, Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands. Vaccine. ,vol. 25, pp. 6245- 6256 ,(2007) , 10.1016/J.VACCINE.2007.05.061
Shalini L. Kulasingam, Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs JAMA. ,vol. 290, pp. 781- 789 ,(2003) , 10.1001/JAMA.290.6.781
Marc Brisson, Nicolas Van de Velde, Philippe De Wals, Marie-Claude Boily, The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine. ,vol. 25, pp. 5399- 5408 ,(2007) , 10.1016/J.VACCINE.2007.04.086
Philippe Beutels, Paul A Scuffham, C Raina MacIntyre, Funding of drugs: do vaccines warrant a different approach? Lancet Infectious Diseases. ,vol. 8, pp. 727- 733 ,(2008) , 10.1016/S1473-3099(08)70258-5
James S. Koopman, Modeling infection transmission- the pursuit of complexities that matter. Epidemiology. ,vol. 13, pp. 622- 624 ,(2002) , 10.1097/00001648-200211000-00004
EJ Dasbach, RP Insinga, EH Elbasha, The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK BJOG: An International Journal of Obstetrics & Gynaecology. ,vol. 115, pp. 947- 956 ,(2008) , 10.1111/J.1471-0528.2008.01743.X
Shalini Kulasingam, Luke Connelly, Elizabeth Conway, Jane S. Hocking, Evan Myers, David G. Regan, David Roder, Jayne Ross, Gerard Wain, A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program. Sexual Health. ,vol. 4, pp. 165- 175 ,(2007) , 10.1071/SH07043